Commission Implementing Regulation (EU) 2023/2649 of 28 November 2023 granting a Union authorisation for the single biocidal product Hokoex in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2023/2649of 28 November 2023granting a Union authorisation for the single biocidal product Hokoex in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(Text with EEA relevance)THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal productsOJ L 167, 27.6.2012, p. 1., and in particular Article 44(5), first subparagraph, thereof,Whereas:(1)On 12 December 2017, Hokochemie GmbH submitted to the European Chemicals Agency ("the Agency") an application in accordance with Article 43(1) of Regulation (EU) No 528/2012 for Union authorisation of a single biocidal product named "Hokoex" of product-type 18, as described in Annex V to that Regulation, providing written confirmation that the competent authority of Switzerland had agreed to evaluate the application. The application was recorded under case number BC-TH035808-24 in the Register for Biocidal Products.(2)"Hokoex" contains cyromazine as the active substance included in the Union list of approved active substances referred to in Article 9(2) of Regulation (EU) No 528/2012 for product-type 18.(3)On 25 March 2021, the evaluating competent authority submitted, in accordance with Article 44(1) of Regulation (EU) No 528/2012, an assessment report and the conclusions of its evaluation to the Agency.(4)On 4 November 2021, the Agency submitted its opinionECHA opinion of 14 October 2021 on the Union authorisation of the biocidal product "Hokoex" (ECHA/BPC/297/2021), https://echa.europa.eu/it/opinions-on-union-authorisation., the draft summary of the biocidal product characteristics ("SPC") of "Hokoex" and the final assessment report on the single biocidal product, to the Commission in accordance with Article 44(3) of Regulation (EU) No 528/2012.(5)The opinion concludes that "Hokoex" is a single biocidal product within the meaning of Article 3(1), point (r), of Regulation (EU) No 528/2012, that it is eligible for Union authorisation in accordance with Article 42(1) of that Regulation and that, subject to compliance with the draft summary of the biocidal product characteristics (SPC), it meets the conditions laid down in Article 19(1) of that Regulation.(6)On 2 December 2021, the Agency transmitted to the Commission the draft SPC in all the official languages of the Union in accordance with Article 44(4) of Regulation (EU) No 528/2012.(7)The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for "Hokoex".(8)The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,HAS ADOPTED THIS REGULATION: